Role of PCSK9 inhibition during the inflammatory stage of SARS-COV-2: an updated review
Description
The potential role of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition in the management of COVID-19 and other medical conditions has emerged as an intriguing area of research. PCSK9 is primarily known for its impact on cholesterol